Cargando…
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
Fragment based drug discovery has long been used for the identification of new ligands and interest in targeted covalent inhibitors has continued to grow in recent years, with high profile drugs such as osimertinib and sotorasib gaining FDA approval. It is therefore unsurprising that covalent fragme...
Autores principales: | McAulay, Kirsten, Bilsland, Alan, Bon, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694498/ https://www.ncbi.nlm.nih.gov/pubmed/36355538 http://dx.doi.org/10.3390/ph15111366 |
Ejemplares similares
-
Fragment‐based drug discovery—the importance of high‐quality molecule libraries
por: Bon, Marta, et al.
Publicado: (2022) -
Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021) -
Correction: Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021) -
PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery
por: Ma, Huiyong, et al.
Publicado: (2022) -
Rapid
Covalent-Probe Discovery by Electrophile-Fragment
Screening
por: Resnick, Efrat, et al.
Publicado: (2019)